Arbutus Biopharma (ABUS) Reports In-Line Q3 EPS; Cash and Cash Equivalents of 151.9M

Go back to Arbutus Biopharma (ABUS) Reports In-Line Q3 EPS; Cash and Cash Equivalents of 151.9M
(NASDAQ: ABUS) Delayed: 4.71 --0 (-0%)
Previous Close $4.71    52 Week High $5.88 
Open $4.71    52 Week Low $2.65 
Day High $4.71    P/E N/A 
Day Low $4.71    EPS $0.00 
Volume 580